ABSTRACT
Aim: Pharmaceutical quality issues have been identified as a serious global or public health concern, especially in low- and middle-income countries including Pakistan. The 2020 “Fake Drug Crisis” functioned as the catalyst for reforming the country’s regulatory institutions and created autonomous “Drug Regulatory Authority of Pakistan.” While it is true that Pakistan has the large pharmaceutical sector, the country has the serious lack of scholarly studies and scientific information addressing medication quality besides incidence of imitation in addition low-quality goods. The current story study discusses essential aspects of Pakistan’s pharmaceutical regulatory structure, including the national pharmaceutical sector, and a gathering and evaluation of existing material to describe the country’s status in terms of overall medication quality.
Methods: Information on quality of drugs published in peer-reviewed journals, research papers, notices, in addition alerts delivered through World Medical Association in addition additional authorities remained retrieved also gathered. Postgraduate dissertations have been employed to represent unreported research information, and medication safety alerts delivered by resident Pakistan authority have been investigated to understand type also frequency of pharmaceutical quality defects recorded.
Results: This is apparent that there is little scientific evidence accessible in Pakistan on the subject of drug quality. Information from the literature cannot support the expected figure of 46-52% of poor-quality medications in Pakistan. Available technologies and methods utilized in the latest days at the world level, particularly in emerging nations have also been studied, also suggestions for Pakistan to tackle battle in contradiction of low-quality medications have been developed.
Conclusion: The reports available, inspections, and general statistics for Pakistan indicate the necessity for stronger regulatory procedures for facilities and GMP examinations, analyzing laboratories, and comprehensive size building in field of identifying also regulating defective also fraudulent medications. This is advised that well-planned also adequately financed research be conducted in order to obtain important statistics on the incidence of inferior and counterfeit pharmaceuticals in Pakistan.
Keywords: Pharmaceutical Quality Difficulties, Public Health Issue, Middle-Income Nations.